Nexalin Technology, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Nexalin Technology, Inc. (NXL) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of 3.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2026-03-25
- Nexalin Technology, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was 3.00%, a 50.00% increase from fiscal 2023.
- Nexalin Technology, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was 2.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2024-12-31 | 3.00% 10-K · filed 2026-03-25 |
| 2023-12-31 | 2.00% 10-K/A · filed 2025-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |